Related Experiment Video

Updated: Sep 26, 2026

Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses
11:19

Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses

Published on: February 25, 2011

Inhibition of bacterial IF2 binding to fMet-tRNA((fMet)) by aminoglycosides

J M Evans1, B A Turner, S Bowen

  • 1Global High Throughput Screening, Pharmacia Corp., Kalamazoo, MI 49007, USA.

Bioorganic & Medicinal Chemistry Letters
|March 20, 2003
PubMed

Insights

Aminoglycosides like amikacin inhibit bacterial protein synthesis by binding to N-formyl-Methionyl-transfer RNA (fMet-tRNA), not Initiation Factor 2 (IF2). This discovery offers new insights into antibiotic mechanisms.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Bacterial protein synthesis is a crucial target for antibiotics.
  • Initiation Factor 2 (IF2) plays a vital role in initiating protein synthesis by binding to N-formyl-Methionyl-transfer RNA (fMet-tRNA).
  • Understanding the precise molecular interactions in this process can lead to the development of novel antibacterial agents.

Purpose of the Study:

  • To identify inhibitors of the interaction between bacterial IF2 and fMet-tRNA.
  • To elucidate the mechanism of action of identified inhibitors.

Main Methods:

  • Screening of compounds for inhibition of IF2-fMet-tRNA binding.
  • Assessing the range of inhibitory activity of identified compounds.
  • Investigating the binding interactions using PicoGreen displacement assays.
  • Conducting isothermal denaturation experiments to study protein-ligand interactions.

Main Results:

  • A series of aminoglycosides, including amikacin and kanamycin A1, were identified as inhibitors of IF2-fMet-tRNA binding.
  • Aminoglycosides exhibited varying degrees of inhibitory activity.
  • Evidence suggests aminoglycosides primarily bind to fMet-tRNA rather than IF2.
  • Isothermal denaturation experiments showed no direct interaction between IF2 protein and aminoglycosides.

Conclusions:

  • Aminoglycosides inhibit bacterial protein synthesis initiation by targeting fMet-tRNA.
  • This binding to fMet-tRNA, rather than IF2, represents a distinct mechanism of action.
  • Findings provide a deeper understanding of aminoglycoside antibiotic function and potential for new drug development.

More Related Videos

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects13:57

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects

Published on: February 18, 2014

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...